Logo + Home
 

Literatur

Alberta Medical Association (AMA).
Guideline for the diagnosis and management of community acquired pneumonia: adult. Update 2008.
http://www.topalbertadoctors.org/PDF/complete%20set/Pneumonia_Community%20Aquired%20Adult/CAP_adult_guideline.pdf

British Thoracic Society (BTS).
BTS Guidelines for the Management of Community Acquired pneumonia in Adults – 2004 Update.
Published on BTS website on 30.04.2004. http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Pneumonia/Guidelines/MACAPrevisedApr04.pdf"

European Respiratory Society (ERS).
ERS Task Force in Collaboration with ESCMID. Guidelines for the management of adult lower respiratory tract infection.
European Respiratory Journal 2005; 26: 1138-1180.

Halm EA, Fine MJ, Kapoor WN, Singer DE, Marrie TJ, Siu AL.
Instability on Hospital Discharge and the Risk of Adverse Outcomes in Patients with Pneumonia.
Arch intern med 2002; 162: 1278-1284.

Halm EA, Fine MJ, Marrie TJ, Coley CM, Kapoor WN, Obrosky DS, Singer DE.
Time to Clinical Stability in Patients with Community-Acquired Pneumonia – Implications for Practice Guidelines.
JAMA 1998; 279 (18): 1452-1457.

Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, Dietrich E, Ewig S, Gastmeier P, Grabeln B, Halle E, Kolditz M, Marre R, Sitter H.
Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen tiefen Atemwegsinfektionen (akute Bronchitis, akute Exazerbation einer chronischen Bronchitis, Influenza und andere respiratorische Virusinfektionen) sowie ambulant erworbener Pneumonie. S3-Leitlinie der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., der Deutschen Gesellschaft für Pneumonie, der Deutschen Gesellschaft für Infektiologie und vom Kompetenznetzwerk CAPNETZ.
Chemotherapie-Journal 2005; 14 (4): 97-155.

Infectious Diseases Society of America (IDSA), American Thoracic Society (ATS).
Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults.
Clinical Infectious Diseases 2007; 44: 27-72. http://www.journals.uchicago.edu/doi/pdf/10.1086/511159

Kohlhammer Y, Schwartz M, Raspe H, Schäfer T.
Risiko­faktoren für die ambulant erworbene Pneumonie (Community Acquired Pneumonia) – Eine systematische Übersichtsarbeit.
Dtsch med Wochenschr 2005; 130: 381-386.

Kompetenznetz Ambulant erworbene Pneumonie (CAPNETZ).
Was gibt es Neues in der Behandlung der ambulanterworbenen Pneumonie?
Medizinische Klinik 2006; 101: 313-320.

Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG.
A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.
JAMA 2000; 283 (6): 749-755.

Meehan TP, Fine MJ, Krumholz HM, Scinto JD, Galusha DH, Mockalis JT, Weber GF, Perillo MK, Houck PM, Fine JM.
Quality of Care, Process, and Outcoms in Elderly Patients With Pneumonia.
JAMA 1997; 278 (23): 2080-2084.

Menéndez R, Torres A, Zalacaín R, Aspa J, Martín Villasclaras JJ, Borderías L, Benítez Moya JM, Ruiz-Manzano J, Rodríguez de Castro F, Blanquer J, Pérez D, Puzo C, Sánchez Gascón, Gallardo J, Álvarez C, Molinos L (Neumofail Group).
Risk Fac­tors of treatment failure in community acquired pneumonia: implications for disease outcome.
Thorax 2004; 59: 960-965.

Recherchedatum der Internet-Links: 29.05.2009